Patents by Inventor Martin Zeltner

Martin Zeltner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240026662
    Abstract: A heating and pumping system is disclosed. The system may be usable in a portable sink that includes a clean water source having incorporated therein the system with a submersible heater. The heater may include an enclosed heating element that transfers thermal energy (heat) to the water in the clean tank. A powered and/or automatic pump may be provided to move water relative to the heater. A controller with the system may control the operation of the heater and/or the pump to achieve the selected temperature of the clean water.
    Type: Application
    Filed: July 18, 2023
    Publication date: January 25, 2024
    Inventors: Martin ZELTNER, Michael Scot COOPER, Arash SHEIKHTAHERI
  • Patent number: 11827721
    Abstract: The present invention relates to the field of antibodies useful in therapy and diagnosis. It specifically discloses bioconjugates comprising one or more antibodies bound to functionalized, magnetic nanoparticles. These bioconjugates are useful in cancer therapy, particularly for removing circulating tumor cells. The invention further pertains to specific functionalized, magnetic nanoparticles and to the manufacturing of such bioconjugates and such functionalized, magnetic nanoparticles.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: November 28, 2023
    Assignee: Universität Zürich and ETH Zurich
    Inventors: Antoine Florent Herzog, Wendelin Jan Stark, Martin Zeltner, Beatrice Beck-Schimmer, Anja Zabel
  • Publication number: 20200399401
    Abstract: The present invention relates to the field of antibodies useful in therapy and diagnosis. It specifically discloses bioconjugates comprising one or more antibodies bound to functionalized, magnetic nanoparticles. These bioconjugates are useful in cancer therapy, particularly for removing circulating tumor cells. The invention further pertains to specific functionalized, magnetic nanoparticles and to the manufacturing of such bioconjugates and such functionalized, magnetic nanoparticles.
    Type: Application
    Filed: February 25, 2019
    Publication date: December 24, 2020
    Applicants: Universität Zürich, ETH Zurich
    Inventors: Antoine Florent Herzog, Wendelin Jan Stark, Martin Zeltner, Beatrice Beck-Schimmer, Anja Zabel
  • Patent number: D1025844
    Type: Grant
    Filed: April 24, 2023
    Date of Patent: May 7, 2024
    Assignee: Invacare International GmbH
    Inventors: Simon Brenner, Martin Hunig, Michael Zeltner
  • Patent number: D1025845
    Type: Grant
    Filed: April 24, 2023
    Date of Patent: May 7, 2024
    Assignee: Invacare International GmbH
    Inventors: Simon Brenner, Martin Hunig, Michael Zeltner